Tenaya Therapeutics, Inc. (TNYA)
0.8573
-0.08
(-8.31%)
USD |
NASDAQ |
May 15, 16:00
0.84
-0.02
(-2.02%)
After-Hours: 20:00
Tenaya Therapeutics EPS Diluted (Quarterly) : -0.0889 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -0.1646 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Krystal Biotech, Inc. | 1.833 |
| Vericel Corp. | -0.1241 |
| Anavex Life Sciences Corp. | -0.0638 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.27M |
| Revenue (Quarterly) | 0.225M |
| Total Expenses (Quarterly) | 19.50M |
| Enterprise Value | 115.26M |
| Gross Profit Margin (Quarterly) | -683.6% |
| Profit Margin (Quarterly) | -8.57K% |
| Earnings Yield | -54.96% |
| Normalized Earnings Yield | -54.97 |